Search

everythinglearnresearchcommunity

for

Search:↓

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Imuvert can prevent some chemotherapy-induced hair loss.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Longdan Xiegan decoction is more effective than conventional medicine for treating eczema.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Skin reactions from cancer treatments might predict how well the treatments work.